2-((Tetrahydro-2H-pyran-4-yl)oxy)ethan-1-ol

Catalog No.: 
ACTBND602
CAS No.: 
398487-56-4
Molecular Formula: 
C7H14O3
Molecular Weight: 
146.19
2-((Tetrahydro-2H-pyran-4-yl)oxy)ethan-1-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$188.00In stockInquiry
250mg97%$375.00In stockInquiry
1g97%$1091.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((Tetrahydro-2H-pyran-4-yl)oxy)ethan-1-ol
IUPAC Name2-((tetrahydro-2H-pyran-4-yl)oxy)ethan-1-ol
MDL No.MFCD16102822
Molecular FormulaC7H14O3
Molecular Weight146.19
SMILESOCCOC1CCOCC1
InChI KeyLZECSOMGRCGVFL-UHFFFAOYSA-N
Synonym2-(OXAN-4-YLOXY)ETHAN-1-OL(WXC08211);2-(Oxan-4-yloxy)ethan-1-ol;Ethanol, 2-[(tetrahydro-2H-pyran-4-yl)oxy]-;2-[(Tetrahydro-2H-pyran-4-yl)oxy]ethanol;2-[(4-Tetrahydropyranyl)oxy]ethanol;2-((tetrahydro-2H-pyran-4-yl)oxy)ethan-1-ol
CAS No.398487-56-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACTBND602 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBLIJ086 route compound structure diagram
    ACBLIJ0862081-44-9In Stock
  4. Then
  5. ACTBND602 route product structure diagram
    ACTBND602398487-56-4In Stock
Inquiry

2. ACTBND602 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTBND602 route product structure diagram
    ACTBND602398487-56-4In Stock
Inquiry

3. ACTBND602 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTBND602 route product structure diagram
    ACTBND602398487-56-4In Stock
Inquiry

Comments (0)